Published in NIDA Res Monogr on January 01, 1990
The UCSC Genome Browser Database. Nucleic Acids Res (2003) 32.84
Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31
The UCSC Genome Browser Database: update 2006. Nucleic Acids Res (2006) 11.05
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci (1991) 5.88
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A (1990) 5.48
Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development (2001) 5.46
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse (2001) 4.03
The genes for fifteen ribosomal proteins of Saccharomyces cerevisiae. J Biol Chem (1981) 4.02
Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol (2000) 2.93
The share of human genomic DNA under selection estimated from human-mouse genomic alignments. Cold Spring Harb Symp Quant Biol (2003) 2.83
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Messenger RNA for ribosomal proteins in yeast. J Mol Biol (1983) 2.41
Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther (1993) 2.40
Sigma receptors: biology and function. Pharmacol Rev (1990) 2.37
Sporulation of Clostridium perfringens in a modified medium and selected foods. Appl Microbiol (1967) 2.36
The nifA gene of Rhizobium meliloti is oxygen regulated. J Bacteriol (1987) 2.32
Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab (1993) 2.28
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Mild temperature shock alters the transcription of a discrete class of Saccharomyces cerevisiae genes. Mol Cell Biol (1983) 2.19
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization. Mol Pharmacol (2006) 2.06
Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol (1997) 1.87
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet (2001) 1.80
The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol (2009) 1.78
Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis (1987) 1.77
Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors? Science (1977) 1.77
Survival of Clostridium perfringens During Baking and Holding of Turkey Stuffing. Appl Microbiol (1966) 1.73
Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology (2000) 1.72
C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol (2001) 1.71
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther (2005) 1.70
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A (2000) 1.69
Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis (1983) 1.62
Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn. Eur J Immunol (1999) 1.61
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology (1996) 1.57
Effect of a lipidic extract from lepidium meyenii on sexual behavior in mice and rats. Urology (2000) 1.56
Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci (2012) 1.55
Variability in nocturnal nitrogen oxide processing and its role in regional air quality. Science (2006) 1.54
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem (2001) 1.54
Schatzki's ring: long-term results following dilation. Gastrointest Endosc (1990) 1.51
The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR. J Mol Biol (1997) 1.51
Specific stimulation of simian virus 40 late transcription in vitro by a cellular factor binding the simian virus 40 21-base-pair repeat promoter element. Proc Natl Acad Sci U S A (1987) 1.50
Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther (2006) 1.50
An extended medial to lateral approach to mobilize the splenic flexure during laparoscopic low anterior resection. Colorectal Dis (2013) 1.47
Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat Immunol (2001) 1.47
Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. Bone (2002) 1.47
Innate immunity as orchestrator of stem cell mobilization. Leukemia (2010) 1.46
Hypothesis that mesolimbic dopamine (DA) plays a key role in mediating the reinforcing effects of drugs of abuse as well as the rewarding effects of ingestive behaviors. J Subst Abuse Treat (1994) 1.45
The complete amino acid sequence of bovine heart cytochrome C1. Biochem Biophys Res Commun (1980) 1.43
Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone. J Med Chem (1978) 1.43
Inflammatory bowel disease: Part I. Clinical features and diagnosis. Am Fam Physician (1993) 1.41
Inflammatory bowel disease: Part II. Medical and surgical management. Am Fam Physician (1993) 1.40
Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin. J Obstet Gynaecol (2009) 1.39
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assay. Synapse (2001) 1.39
Reevaluation of a weight-based heparin dosing nomogram: is institution-specific modification necessary? Ann Pharmacother (1997) 1.38
Cryptic reproductive isolation in the Drosophila simulans species complex. Evolution (2001) 1.36
Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc Natl Acad Sci U S A (1985) 1.35
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta. Neuroscience (2010) 1.33
Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res (2011) 1.32
A tetrodotoxin-producing Vibrio strain, LM-1, from the puffer fish Fugu vermicularis radiatus. Appl Environ Microbiol (2000) 1.31
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. J Med Chem (1999) 1.31
A relation between inhibition of protein synthesis and conformation of 5'-phosphorylated 7-methylguanosine derivatives. J Mol Biol (1977) 1.31
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther (1995) 1.30
Overlapping transcription of the nifA regulatory gene in Rhizobium meliloti. Gene (1986) 1.30
Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology (2012) 1.28
NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2. Genomics (1993) 1.25
Genetic structuring and transfer of marine dinoflagellate Cochlodinium polykrikoides in Japanese and Korean coastal waters revealed by microsatellites. Mol Ecol (2009) 1.24
Goat blood agar. Inexpensive media for culturing common bacterial pathogens. Trop Doct (1986) 1.23
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience (2008) 1.22
Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid. Dev Biol (1997) 1.22
Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience (2010) 1.22
Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol (1999) 1.22
Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci U S A (1986) 1.20
Characterization of a bifunctional enzyme fusion of trehalose-6-phosphate synthetase and trehalose-6-phosphate phosphatase of Escherichia coli. Appl Environ Microbiol (2000) 1.20
Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci (2009) 1.20
RNA sequence and secondary structural determinants in a minimal viral promoter that directs replicase recognition and initiation of genomic plus-strand RNA synthesis. J Mol Biol (1999) 1.18
Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol (2001) 1.16
Neuropeptides and their receptors: a psychosomatic network. J Immunol (1985) 1.15
Spatial configuration of mRNA 5'-terminus. Nature (1977) 1.15
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine. J Med Chem (1998) 1.14
Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides (1990) 1.14
Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene. J Neurochem (1998) 1.13
A comparison of voluntarily reported medication errors in intensive care and general care units. Qual Saf Health Care (2010) 1.11
Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther (2001) 1.11
CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol (1999) 1.11
Mechanisms of conspecific sperm precedence in Drosophila. Evolution (2000) 1.10
Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand. J Biol Chem (1987) 1.10
Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science (1985) 1.10
Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am J Chin Med (2000) 1.09
Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors. J Med Chem (1985) 1.09
Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann N Y Acad Sci (1999) 1.08
Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp Hematol (1999) 1.08
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. Pharmacol Biochem Behav (2006) 1.08
Development of the stress response inventory and its application in clinical practice. Psychosom Med (2001) 1.08